-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pulmonary artery angioplasty (PAA) is an important surgical procedure that completes radical resection in the case of pulmonary artery involvement to maximize the preservation of lung tissue function
.
In this study, the purpose of this study was to evaluate the short- and long-term outcomes of lobectomy and PAA using video-assisted thoracoscopy (VATS) versus thoracotomy (OT) in lung cancer surgery
Pulmonary artery angioplasty (PAA) is an important surgical procedure that completes radical resection in the case of pulmonary artery involvement to maximize the preservation of lung tissue function
We retrospectively studied 214 patients who received PAA between November 2005 and October 2016
.
Propensity score matching (PSM) was used to reduce confounding effects
We retrospectively studied 214 patients who received PAA between November 2005 and October 2016
The final study included 203 patients (28 in the VATS group and 175 in the OT group)
There were no differences between the two groups in terms of operation time, blood loss, chest tube drainage time, postoperative hospital stay, surgical margin, postoperative morbidity, mortality, number of N1 and N2 stations, and number of N1 and N2 lymph nodes before and after matching
.
.
With a median follow-up of 43 months (6-158 months), the 5-year overall survival (OS) and recurrence-free survival (RFS) of the entire cohort were 47.
9% and 42.
1%, respectively
.
9% and 42.
1%, respectively
.
With a median follow-up of 43 months (6-158 months), the 5-year overall survival (OS) and recurrence-free survival (RFS) of the entire cohort were 47.
5-year OS in the VATS and OT groups in the overall cohort [49.
Differences in OS before PSM treatment
Differences in OS before PSM treatmentDifferences in treatment OS after PSM
Differences in treatment OS after PSMLikewise, the 5-year RFS rates in the VATS and OT groups were higher in the overall cohort [39.
1% (95% CI: 23.
4 65.
2%) vs.
42.
6% (95% CI: 35.
4 51.
1%)] and matched cohorts [39.
1% (95%) CI: 23.
4 65.
2%) vs.
44.
1% (95% CI: 32.
1 60.
5%)]
.
1% (95% CI: 23.
4 65.
2%) vs.
42.
6% (95% CI: 35.
4 51.
1%)] and matched cohorts [39.
1% (95%) CI: 23.
4 65.
2%) vs.
44.
1% (95% CI: 32.
1 60.
5%)]
.
Likewise, the 5-year RFS rates in the VATS and OT groups were higher in the overall cohort [39.
Differences in RFS before PSM treatment
Differences in RFS before PSM treatmentTreatment RFS Differences After PSM
Treatment RFS Differences After PSMN2 lymph node dissection ≥ 11 (hazard ratio 0.
36; 95% CI: 0.
14 - 0.
93, P=0.
035) was the only factor favorable for OS
.
Charlson comorbidity index 2 (hazard ratio, 0.
N2 lymph node dissection ≥ 11 (hazard ratio 0.
In conclusion, studies have shown that video-assisted thoracoscopy (VATS) is comparable to thoracotomy (OT) for lobectomy and PAA in the treatment of lung cancer patients
.
Studies have shown that video-assisted thoracoscopy (VATS) is comparable to thoracotomy (OT) for lobectomy and PAA in the treatment of lung cancer patients
.
Studies have shown that video-assisted thoracoscopy (VATS) is comparable to thoracotomy (OT) for lobectomy and PAA in the treatment of lung cancer patients
.
Original source:
Original source:Liu C, Yang Z, Guo C, Zhu Y, Pu Q, Mei J, Ma L, Lin F, Liu L.
Lobectomy with pulmonary artery angioplasty for lung cancer using video-assisted thoracic surgery versus open thoracotomy: a retrospective propensity matched analysis .
Transl Lung Cancer Res 2021;10(10):3943-3956.
doi: 10.
21037/tlcr-21-607
Lobectomy with pulmonary artery angioplasty for lung cancer using video-assisted thoracic surgery versus open thoracotomy: a retrospective propensity matched analysis .
Transl Lung Cancer Res 2021;10(10):3943-3956.
doi: 10.
21037/tlcr-21-607 Leave a comment here